Communication, FDA, Immunization and Vaccines

Pharmacy Measures and Policy Considerations for Pharmacy Practice

PQA

DECEMBER 15, 2022

Immunization Authority – PQA has prioritized pharmacy performance measure concepts related to immunizations. To support pharmacists’ ability to assess patients’ immunization needs and successfully close gaps in care related to vaccinations, immunization authority should be consistent across states and pharmacy practice sites.

Immunization

Immunization Vaccines Specialty Pharmacies Communication

Methylprednisolone interactions to avoid

The Checkup by Singlecare

OCTOBER 6, 2023

Key takeaways: Methylprednisolone is an effective therapeutic agent to control immune responses and inflammation. The interaction is severe enough that prescribing information for many NSAIDs warns against the concomitant use of corticosteroids in a Food and Drug Administration (FDA) issued Medication Guide.

Vaccines

Vaccines Mayo Clinic FDA Immunization

Herd immunity is nice – but what about me?

pharmaphorum

JULY 5, 2021

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. While these numbers do tell us something about the relative immunity of the population writ large, they don’t tell us anything about our own, personal immune profiles. However, we’ve also found a number of outliers.

Immunization

Immunization Health and Personal Care Stores Vaccines Adverse Reactions

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Immunization

Immunization Vaccines Communication Labelling

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines

Vaccines Immunization Medical Schools FDA

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines

Vaccines Immunization Medical Schools FDA

Pharmacy Star Ratings Changes Coming in 2023

Digital Pharmacist

NOVEMBER 21, 2022

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.

Communication

Communication Documentation Immunization Vaccines

Contamination Trends & Proposed Solutions

ISPE

MARCH 8, 2023

Identification and Analysis of Contamination Trends Three major recall databases—those of the US FDA, the United Kingdom’s Medicine and Healthcare Products Regulatory Agency (UK MHRA), and Australia’s Therapeutic Goods Administration (TGA)—were searched to assess contamination trends in the past five years.

Compounding

Compounding Compounding Pharmacies Packaging FDA

Can amoxicillin treat STDs?

The Checkup by Singlecare

MARCH 28, 2024

Food and Drug Administration (FDA) to treat many bacterial infections. Amoxicillin is FDA-approved for treating nose, throat, ear, lung, skin, and urinary tract infections. Without cell walls, bacteria can’t survive and are more easily cleared by your immune system. Amoxicillin is an antibiotic approved by the U.S.

Dosage

Dosage FDA Labelling Communication

FDA grants GSK first-ever approval for RSV vaccine

Pharmaceutical Technology

MAY 4, 2023

After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD).

Vaccines

Vaccines FDA Communication Immunization

Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

Vaccines

Vaccines Immunization Medical Schools FDA

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Pharmaceutical Technology

MARCH 21, 2023

FDA and EMA decisions In January, the European Commission (EC) approved Roche’s Xofluza (baloxavir marboxil) to prevent and treat influenza in children ages one year and older. Regulatory decisions by the FDA and EMA for select therapies from late January to late February and the CMOs contracted to manufacture the therapies.

Packaging

Packaging FDA Vaccines Labelling

Pharmacy Technician Pulse

Pharmacy Measures and Policy Considerations for Pharmacy Practice

Methylprednisolone interactions to avoid

Trending Sources

Herd immunity is nice – but what about me?

Paving the way for anti-Abeta active immunotherapy

Race to the finish: pharma edges closer to approval with RSV vaccines

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

Pharmacy Star Ratings Changes Coming in 2023

Contamination Trends & Proposed Solutions

Can amoxicillin treat STDs?

FDA grants GSK first-ever approval for RSV vaccine

Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies

Covid-19 vaccine success bolsters nanoparticle drug delivery research

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Stay Connected